A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

Inclusion Criteria: * Male and female patients 12 years of age and older * Must be in generally good health * Must meet minimum symptom requirements, as specified in protocol * Must be willing and able to provide informed consent and participate in all study procedures * 2-year history of PAR * Positive skin test to cockroach, dust mite, mold or cat/dog dander Exclusion Criteria: * On nasal examination, presence of any nasal mucosal erosion, nasal ulceration or nasal septal perforation at the screening or randomization visit * Nasal diseases likely to affect deposition of intranasal medication, such as sinusitis, rhinitis medicamentosa, significant polyposis or nasal structural abnormalities * Nasal surgery or sinus surgery within the previous year * The use of any investigational drug within 30 days * Presence of any hypersensitivity to drugs similar to azelastine and to either sorbitol or sucralose * Women who are pregnant or nursing * Women of child-bearing potential who are not abstinent and not practicing a medically acceptable method of contraception * Respiratory tract infection within 2 weeks of screening * Respiratory tract infections requiring oral antibiotic treatment within 2 weeks of screening * Patients with asthma with the exception of mild, intermittent * Significant pulmonary disease including COPD * Patients with arrhythmia * Patients with a known history of alcohol or drug abuse * Existence of any surgical or medical condition, which in the opinion of the investigator or sponsor may significantly alter the absorption, distribution, metabolism or excretion of study drug. * Clinically relevant abnormal physical findings within one week of randomization * Overnight abscences from home for more than 3 nights * Employees of the research center or private practice and family members are excluded * Patients who received prohibited medications within specified timepoints in protocol.